1. Home
  2. ABR vs PCRX Comparison

ABR vs PCRX Comparison

Compare ABR & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbor Realty Trust

ABR

Arbor Realty Trust

HOLD

Current Price

$4.37

Market Cap

938.4M

Sector

Real Estate

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$24.00

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABR
PCRX
Founded
2003
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
938.4M
1.1B
IPO Year
2003
2010

Fundamental Metrics

Financial Performance
Metric
ABR
PCRX
Price
$4.37
$24.00
Analyst Decision
Hold
Strong Buy
Analyst Count
5
4
Target Price
$9.90
$30.25
AVG Volume (30 Days)
3.6M
430.8K
Earning Date
05-08-2026
04-30-2026
Dividend Yield
15.42%
N/A
EPS Growth
N/A
107.44
EPS
N/A
0.19
Revenue
N/A
$541,533,000.00
Revenue This Year
N/A
$6.78
Revenue Next Year
N/A
$8.54
P/E Ratio
N/A
$129.32
Revenue Growth
N/A
26.04
52 Week Low
$4.24
$18.80
52 Week High
$12.58
$27.66

Technical Indicators

Market Signals
Indicator
ABR
PCRX
Relative Strength Index (RSI) 29.57 43.11
Support Level N/A $21.97
Resistance Level $5.41 $27.05
Average True Range (ATR) 0.16 0.74
MACD -0.07 -0.17
Stochastic Oscillator 13.37 22.70

Price Performance

Historical Comparison
ABR
PCRX

About ABR Arbor Realty Trust

Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily, SFR, and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: